$CVS
CVS HEALTH Corp

2012 Q3 Form 10-Q Financial Statement

#000110465912074770 Filed on November 06, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2011 Q4 2011 Q3
Revenue $30.24B $28.32B $26.67B
YoY Change 13.36% 15.16% 12.5%
Cost Of Revenue $24.58B $22.76B $21.50B
YoY Change 14.35% 18.95% 14.98%
Gross Profit $5.645B $5.555B $5.178B
YoY Change 9.02% 1.85% 3.25%
Gross Profit Margin 18.67% 19.62% 19.41%
Selling, General & Admin $3.833B $3.598B $3.594B
YoY Change 6.65% -2.57% 1.61%
% of Gross Profit 67.9% 64.77% 69.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.833B $3.598B $3.594B
YoY Change 6.65% -2.57% 1.61%
Operating Profit $1.812B $1.957B $1.584B
YoY Change 14.39% 11.13% 7.17%
Interest Expense $135.0M -$147.0M $156.0M
YoY Change -13.46% 8.09% -213.87%
% of Operating Profit 7.45% -7.51% 9.85%
Other Income/Expense, Net
YoY Change
Pretax Income $1.680B $1.810B $1.429B
YoY Change 17.56% 11.38% 6.56%
Income Tax $669.0M $711.0M $562.0M
% Of Pretax Income 39.82% 39.28% 39.33%
Net Earnings $1.005B $1.063B $867.0M
YoY Change 15.92% 3.61% 7.17%
Net Earnings / Revenue 3.32% 3.75% 3.25%
Basic Earnings Per Share $0.79 $0.82 $0.65
Diluted Earnings Per Share $0.79 $0.81 $0.65
COMMON SHARES
Basic Shares Outstanding 1.265B shares 1.332B shares
Diluted Shares Outstanding 1.274B shares 1.340B shares

Balance Sheet

Concept 2012 Q3 2011 Q4 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.238B $1.418B $1.712B
YoY Change -27.69% -0.91% 74.16%
Cash & Equivalents $1.233B $1.413B $1.707B
Short-Term Investments $5.000M $5.000M $5.000M
Other Short-Term Assets $212.0M $580.0M $946.0M
YoY Change -77.59% -11.45% 43.33%
Inventory $10.49B $10.05B $10.38B
Prepaid Expenses
Receivables $6.407B $6.047B $5.901B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.88B $18.59B $18.94B
YoY Change -0.31% 5.02% 9.22%
LONG-TERM ASSETS
Property, Plant & Equipment $8.369B $8.467B $8.642B
YoY Change -3.16% 1.74% 3.42%
Goodwill $26.42B $26.46B
YoY Change 3.07%
Intangibles $9.801B $9.869B
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.325B $1.155B $1.218B
YoY Change 8.78% 67.88% 159.7%
Total Long-Term Assets $45.92B $46.26B $46.31B
YoY Change -0.86% 4.04% 4.37%
TOTAL ASSETS
Total Short-Term Assets $18.88B $18.59B $18.94B
Total Long-Term Assets $45.92B $46.26B $46.31B
Total Assets $64.80B $64.85B $65.25B
YoY Change -0.7% 4.32% 5.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.091B $4.370B $7.490B
YoY Change -32.03% -33.74% 14.84%
Accrued Expenses $3.618B $3.293B $4.259B
YoY Change -15.05% 7.26% 59.87%
Deferred Revenue
YoY Change
Short-Term Debt $825.0M $750.0M $530.0M
YoY Change 55.66% 150.0% -61.71%
Long-Term Debt Due $5.000M $56.00M $71.00M
YoY Change -92.96% -94.93% -93.57%
Total Short-Term Liabilities $13.26B $11.96B $12.35B
YoY Change 7.39% 8.0% 5.79%
LONG-TERM LIABILITIES
Long-Term Debt $9.210B $9.208B $10.17B
YoY Change -9.41% 6.43% 17.5%
Other Long-Term Liabilities $1.513B $1.445B $1.348B
YoY Change 12.24% 36.58% 27.05%
Total Long-Term Liabilities $10.72B $10.65B $11.52B
YoY Change -6.88% 9.71% 18.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.26B $11.96B $12.35B
Total Long-Term Liabilities $10.72B $10.65B $11.52B
Total Liabilities $23.99B $22.61B $27.76B
YoY Change -13.61% -7.6% 10.72%
SHAREHOLDERS EQUITY
Retained Earnings $24.12B $22.09B
YoY Change
Common Stock $17.00M $16.00M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $15.94B $11.95B
YoY Change
Treasury Stock Shares 415.0M shares 340.0M shares
Shareholders Equity $36.92B $38.05B $37.49B
YoY Change
Total Liabilities & Shareholders Equity $64.80B $64.54B $65.25B
YoY Change -0.7% 3.82% 5.73%

Cashflow Statement

Concept 2012 Q3 2011 Q4 2011 Q3
OPERATING ACTIVITIES
Net Income $1.005B $1.063B $867.0M
YoY Change 15.92% 3.61% 7.17%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $923.0M $821.0M $1.962B
YoY Change -52.96% -53.75% 51.86%
INVESTING ACTIVITIES
Capital Expenditures -$496.0M -$704.0M -$458.0M
YoY Change 8.3% 12.46% -10.72%
Acquisitions
YoY Change
Other Investing Activities $398.0M $857.0M -$39.00M
YoY Change -1120.51% 129.14% -880.0%
Cash From Investing Activities -$98.00M $153.0M -$497.0M
YoY Change -80.28% -160.71% -2.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.415B -1.268B -1.986B
YoY Change -28.75% 17.95% 117.76%
NET CHANGE
Cash From Operating Activities 923.0M 821.0M 1.962B
Cash From Investing Activities -98.00M 153.0M -497.0M
Cash From Financing Activities -1.415B -1.268B -1.986B
Net Change In Cash -590.0M -294.0M -521.0M
YoY Change 13.24% -165.63% 307.03%
FREE CASH FLOW
Cash From Operating Activities $923.0M $821.0M $1.962B
Capital Expenditures -$496.0M -$704.0M -$458.0M
Free Cash Flow $1.419B $1.525B $2.420B
YoY Change -41.36% -36.48% 34.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1547000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2389000000 USD
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
us-gaap Revenues
Revenues
78783000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
63777000000 USD
us-gaap Gross Profit
GrossProfit
15006000000 USD
us-gaap Operating Expenses
OperatingExpenses
10633000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4373000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3936000000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
5647000000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1814000000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1680000000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1011000000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
1006000000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1006000000 USD
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
us-gaap Profit Loss
ProfitLoss
2394000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2397000000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.78
CY2011Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3000000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1350000000 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1356000000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.3750
CY2011Q3 us-gaap Revenues
Revenues
26674000000 USD
CY2011Q3 us-gaap Cost Of Revenue
CostOfRevenue
21496000000 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
5178000000 USD
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
3594000000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1584000000 USD
CY2011Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-155000000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1429000000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
562000000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
867000000 USD
CY2011Q3 us-gaap Profit Loss
ProfitLoss
867000000 USD
CY2011Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
868000000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.65
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1332000000 shares
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.65
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1340000000 shares
CY2011Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1250
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
5000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
us-gaap Gross Profit
GrossProfit
16209000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4925000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4528000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2753000000 USD
us-gaap Profit Loss
ProfitLoss
2746000000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2385000000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2000000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-9000000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1007000000 USD
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
415000000 shares
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2748000000 USD
CY2012Q3 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2011Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
869000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2750000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2388000000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1413000000 USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
5000000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6047000000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
10046000000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
503000000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
580000000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
18594000000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8467000000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
26458000000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9869000000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1155000000 USD
CY2011Q4 us-gaap Assets
Assets
64543000000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4370000000 USD
CY2011Q4 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
3487000000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3293000000 USD
CY2011Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
750000000 USD
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
56000000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11956000000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9208000000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3853000000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1445000000 USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Temporary Equity Carrying Amount
TemporaryEquityCarryingAmount
30000000 USD
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
16000000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
11953000000 USD
CY2011Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
56000000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28126000000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22090000000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-172000000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38051000000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64543000000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
18879000000 USD
CY2012Q3 us-gaap Assets
Assets
64796000000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13263000000 USD
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36916000000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64796000000 USD
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1662000000 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1246000000 shares
us-gaap Proceeds From Customers
ProceedsFromCustomers
72875000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
55625000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
10092000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
3000000 USD
us-gaap Interest Paid
InterestPaid
454000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1672000000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
7000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1168000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds
SaleLeasebackTransactionNetProceeds
11000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1406000000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3000000 USD
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
2000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
230000000 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
26000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1463000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1149000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
508000000 USD
us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
19000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
341000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
12000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2553000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2192000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
280000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1172000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
100000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
134000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
479000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-316000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
173000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
52000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
716000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
980000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-73000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4940000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-180000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5035000000 USD
CY2003Q4 cvs Number Of Competitors Against Whom Putative Actions Are Filed
NumberOfCompetitorsAgainstWhomPutativeActionsAreFiled
2 item
cvs Minimum Initial Maturities Of Short Term Investments
MinimumInitialMaturitiesOfShortTermInvestments
3 month
CY2012Q3 us-gaap Long Term Debt
LongTermDebt
9200000000 USD
CY2012Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
11200000000 USD
CY2012Q2 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.40 pure
CY2012Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
26000000 USD
CY2012Q2 cvs Payments To Option Holder For Acquire Additional Interest In Subsidiaries
PaymentsToOptionHolderForAcquireAdditionalInterestInSubsidiaries
5000000 USD
CY2012Q2 us-gaap Business Acquisition Cost Of Acquired Entity Purchase Price
BusinessAcquisitionCostOfAcquiredEntityPurchasePrice
31000000 USD
CY2003Q4 cvs Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
2 item
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
340000000 shares
CY2011Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
2000000 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1233000000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1427000000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1707000000 USD
CY2012Q3 cvs Percentage Of Consolidated Inventories Affected Due To Change In Accounting Principle
PercentageOfConsolidatedInventoriesAffectedDueToChangeInAccountingPrinciple
0.51 pure
us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Basic Earnings Per Share
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnBasicEarningsPerShare
0.01
CY2012Q3 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Diluted Earnings Per Share
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnDilutedEarningsPerShare
0.01
us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Diluted Earnings Per Share
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnDilutedEarningsPerShare
0.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
9000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.11
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.99
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
46000000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
36.06
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
4.27 year
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1011000000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
868000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2755000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2392000000 USD
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1265000000 shares
CY2012Q3 us-gaap Interest Expense
InterestExpense
135000000 USD
CY2011Q3 us-gaap Interest Expense
InterestExpense
156000000 USD
us-gaap Interest Expense
InterestExpense
399000000 USD
us-gaap Interest Expense
InterestExpense
440000000 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 USD
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000000 USD
CY2012Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-134000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-397000000 USD
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-5000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-7000000 USD
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7900000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5100000 shares
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40900000 shares
us-gaap Cost Of Revenue
CostOfRevenue
75530000000 USD
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1298000000 shares
cvs Reporting Segments Number
ReportingSegmentsNumber
3 item
CY2012Q3 us-gaap Revenues
Revenues
30227000000 USD
CY2003Q4 cvs Number Of Pharmacies Filing Putative Action
NumberOfPharmaciesFilingPutativeAction
2 item
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1281000000 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2011Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000000 shares
CY2012Q3 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
CY2011Q3 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
2000000 shares
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1274000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1290000000 shares
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.80
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.15
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.79
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.14
us-gaap Revenues
Revenues
91739000000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
26422000000 USD
CY2012Q3 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
841000000 USD
CY2011Q3 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
657000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
2500000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
1800000000 USD
CY2012Q3 cvs Guaranteed Store Leases
GuaranteedStoreLeases
77 item
cvs Number Of Adjudication Platforms Under Investigation
NumberOfAdjudicationPlatformsUnderInvestigation
2 item
CY2012Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
26400000000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
26500000000 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
-36000000 USD
CY2012Q3 cvs Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
12876000000 USD
CY2011Q4 cvs Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
12594000000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3075000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2563000000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2725000000 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1640000000 shares
CY2012Q3 us-gaap Inventory Net
InventoryNet
10487000000 USD
CY2012Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
535000000 USD
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
212000000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8369000000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1325000000 USD
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5091000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds
SaleLeasebackTransactionNetProceeds
427000000 USD
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9801000000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
121000000 USD
us-gaap Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
362000000 USD
CY2011Q3 us-gaap Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
118000000 USD
us-gaap Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
338000000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
24580000000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
3833000000 USD
CY2012Q3 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
3724000000 USD
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3618000000 USD
CY2012Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
825000000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
669000000 USD
us-gaap Operating Expenses
OperatingExpenses
11284000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1775000000 USD
CY2012Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1625
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4875
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
5000000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6407000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1297000000 USD
CY2012Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000 USD
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9210000000 USD
CY2012Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3894000000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1513000000 USD
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
15937000000 USD
CY2012Q3 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28914000000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
24123000000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-170000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
84463000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
67464000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
10120000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2000000 USD
us-gaap Interest Paid
InterestPaid
411000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1530000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1314000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
303000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1183000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
75000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
56000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
627000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
677000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
21000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4001000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3937000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
97000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
87000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
296000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
586000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-425000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
142000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
919000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
325000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
68000000 USD
CY2012Q3 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Income From Continuing Operations
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnIncomeFromContinuingOperations
6000000 USD

Files In Submission

Name View Source Status
0001104659-12-074770-index-headers.html Edgar Link pending
0001104659-12-074770-index.html Edgar Link pending
0001104659-12-074770.txt Edgar Link pending
0001104659-12-074770-xbrl.zip Edgar Link pending
a12-19979_110q.htm Edgar Link pending
a12-19979_1ex15d1.htm Edgar Link pending
a12-19979_1ex31d1.htm Edgar Link pending
a12-19979_1ex31d2.htm Edgar Link pending
a12-19979_1ex32d1.htm Edgar Link pending
a12-19979_1ex32d2.htm Edgar Link pending
cvs-20120930.xml Edgar Link completed
cvs-20120930.xsd Edgar Link pending
cvs-20120930_cal.xml Edgar Link unprocessable
cvs-20120930_def.xml Edgar Link unprocessable
cvs-20120930_lab.xml Edgar Link unprocessable
cvs-20120930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending